atorvastatin has been researched along with Carcinogenesis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Atac, MF; Galun, E; Goldberg, SN; Liao, H; Markezana, A; Moussa, M; Mwin, D | 1 |
| Jones, RD; Li, H; Liao, J; Sun, L; Tong, X; Xu, D; Yang, GY | 1 |
| Chang, WL; Clapper, ML; Cooper, HS | 1 |
| Brewer, M; Janakiram, NB; Mohammed, A; Rao, CV; Steele, VE; Vedala, K | 1 |
| Cai, X; Gao, Z; Li, F; Qiu, P; Rakariyatham, K; Song, M; Wang, M; Wu, X; Xiao, H; Xu, F; Zheng, J | 1 |
1 review(s) available for atorvastatin and Carcinogenesis
| Article | Year |
|---|---|
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome | 2020 |
4 other study(ies) available for atorvastatin and Carcinogenesis
| Article | Year |
|---|---|
Myofibroblasts: A key promoter of tumorigenesis following radiofrequency tumor ablation.
Topics: Animals; Atorvastatin; Carcinogenesis; Catheter Ablation; Hepatocyte Growth Factor; Mice; Myofibroblasts; Radiofrequency Ablation; Vascular Endothelial Growth Factor A | 2022 |
Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.
Topics: Animals; Atorvastatin; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; HSP40 Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Mutant Proteins; Pancreas; Pancreatic Neoplasms; Prenylation; Proto-Oncogene Proteins p21(ras); Quinolones; Tumor Suppressor Protein p53 | 2019 |
Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
Topics: Adenomatous Polyps; Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Carcinogenesis; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Eflornithine; Female; Gefitinib; Heptanoic Acids; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; Pyrroles; Quinazolines | 2013 |
Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Azoxymethane; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Flavones; HT29 Cells; Humans; Male; Mice; Rats; Rats, Inbred F344 | 2017 |